Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of Illumina, Inc. (NASDAQ:ILMN)

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Illumina, Inc. (NASDAQ:ILMN). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in Illumina stock on February 10th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Thermon Group (NYSE:THR) on 3/2/2026.
• Purchased $1,001 – $15,000 in shares of Federal Signal (NYSE:FSS) on 3/2/2026.
• Purchased $1,001 – $15,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 2/26/2026.
• Sold $1,001 – $15,000 in shares of Uber Technologies (NYSE:UBER) on 2/24/2026.
• Sold $1,001 – $15,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 2/24/2026.
• Purchased $1,001 – $15,000 in shares of Micron Technology (NASDAQ:MU) on 2/24/2026.
• Sold $1,001 – $15,000 in shares of Oracle (NYSE:ORCL) on 2/24/2026.
• Purchased $1,001 – $15,000 in shares of Champion Homes (NYSE:SKY) on 2/23/2026.
• Sold $1,001 – $15,000 in shares of Tri Pointe Homes (NYSE:TPH) on 2/23/2026.
• Sold $1,001 – $15,000 in shares of Xiaomi (OTCMKTS:XIACF) on 2/20/2026.

Illumina Price Performance

Shares of NASDAQ ILMN traded up $1.56 during midday trading on Tuesday, hitting $120.84. The company had a trading volume of 1,430,204 shares, compared to its average volume of 2,083,222. The firm has a market capitalization of $18.48 billion, a price-to-earnings ratio of 22.17, a price-to-earnings-growth ratio of 2.28 and a beta of 1.45. Illumina, Inc. has a twelve month low of $68.70 and a twelve month high of $155.53. The business has a 50-day simple moving average of $132.18 and a two-hundred day simple moving average of $120.39. The company has a quick ratio of 1.72, a current ratio of 2.08 and a debt-to-equity ratio of 0.55.

Illumina (NASDAQ:ILMN) last issued its earnings results on Thursday, February 5th. The life sciences company reported $1.35 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.09. The company had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.10 billion. Illumina had a net margin of 19.57% and a return on equity of 31.04%. The firm’s revenue for the quarter was up 5.0% compared to the same quarter last year. During the same period in the prior year, the business posted $0.95 earnings per share. Illumina has set its FY 2026 guidance at 5.050-5.200 EPS. Equities research analysts anticipate that Illumina, Inc. will post 4.51 earnings per share for the current year.

Institutional Investors Weigh In On Illumina

Institutional investors have recently bought and sold shares of the stock. Elyxium Wealth LLC acquired a new position in shares of Illumina during the 4th quarter valued at $25,000. Board of the Pension Protection Fund acquired a new position in Illumina during the 4th quarter worth approximately $26,000. Creative Capital Management Investments LLC lifted its position in Illumina by 160.0% during the 4th quarter. Creative Capital Management Investments LLC now owns 195 shares of the life sciences company’s stock worth $26,000 after acquiring an additional 120 shares in the last quarter. TD Waterhouse Canada Inc. purchased a new position in Illumina in the 4th quarter worth approximately $26,000. Finally, Laurel Wealth Advisors LLC purchased a new position in Illumina in the 4th quarter worth approximately $26,000. 89.42% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Illumina

In other news, SVP Patricia Leckman sold 2,370 shares of the business’s stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $116.18, for a total transaction of $275,346.60. Following the transaction, the senior vice president directly owned 16,321 shares of the company’s stock, valued at approximately $1,896,173.78. The trade was a 12.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.17% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on ILMN shares. Evercore set a $150.00 price target on Illumina in a research report on Friday, February 6th. Stifel Nicolaus increased their price objective on Illumina from $135.00 to $155.00 and gave the company a “buy” rating in a research note on Tuesday, January 20th. Guggenheim lifted their price objective on Illumina from $144.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, January 26th. Robert W. Baird set a $137.00 target price on shares of Illumina in a research note on Friday, February 6th. Finally, Zacks Research lowered shares of Illumina from a “strong-buy” rating to a “hold” rating in a report on Wednesday, December 31st. Six research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Illumina presently has an average rating of “Hold” and an average target price of $129.69.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Illumina

Illumina, Inc (NASDAQ: ILMN) is a global life sciences company that develops, manufactures and markets integrated systems for the analysis of genetic variation and function. Headquartered in San Diego, California and founded in 1998, Illumina offers a range of sequencing and array-based technologies used by academic researchers, clinical laboratories, pharmaceutical and biotechnology companies, consumer genomics firms and agricultural researchers to enable discovery, translational research and clinical applications.

The company’s product portfolio includes next-generation sequencing (NGS) platforms and associated consumables, microarrays for genotyping and methylation analysis, library preparation kits and targeted assays.